Gabelli Funds’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-848,344
| Closed | -$7.78M | – | 1486 |
|
|
2021
Q2 | $7.78M | Buy |
848,344
+715,844
| +540% | +$6.56M | 0.05% | 410 |
|
|
2021
Q1 | $659K | Buy |
132,500
+32,500
| +33% | +$162K | ﹤0.01% | 980 |
|
|
2020
Q4 | $431K | Buy |
100,000
+64,000
| +178% | +$276K | ﹤0.01% | 1025 |
|
|
2020
Q3 | $154K | Buy |
36,000
+16,000
| +80% | +$68.4K | ﹤0.01% | 1053 |
|
|
2020
Q2 | $90K | Buy |
20,000
+2,424
| +14% | +$10.9K | ﹤0.01% | 1020 |
|
|
2020
Q1 | $70K | Buy |
17,576
+1,576
| +10% | +$6.28K | ﹤0.01% | 1024 |
|
|
2019
Q4 | $136K | Hold |
16,000
| – | – | ﹤0.01% | 1044 |
|
|
2019
Q3 | $110K | Buy |
16,000
+3,000
| +23% | +$20.6K | ﹤0.01% | 1072 |
|
|
2019
Q2 | $108K | Buy |
+13,000
| New | +$108K | ﹤0.01% | 1100 |
|